0.3771

7.74% 0.0271

Fibrogen Inc (FGEN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché FGEN Giù? Forum Previsione

Precedente Chiudi:

$0.35

Aprire:

$0.3365

Volume 24 ore:

1.17M

Relative Volume:

0.99

Capitalizzazione di mercato:

$35.27M

Reddito:

$147.75M

Utile/perdita netta:

$-284.23M

Rapporto P/E:

-0.1112

EPS:

-3.39

Flusso di cassa netto:

$-317.54M

1 W Prestazione:

+1.95%

1M Prestazione:

+0.69%

6M Prestazione:

-68.31%

1 anno Prestazione:

-22.93%

Intervallo 1D:

$0.3365

$0.3797

Intervallo di 1 settimana:

$0.3288

$0.385

Portata 52W:

$0.18

$2.93

Fibrogen Inc Stock (FGEN) Company Profile

Nome

Fibrogen Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

415-978-1200

Indirizzo

350 BAY STREET, SAN FRANCISCO, CA

Dipendente

486

Cinguettio

@FibroGenInc

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

FGEN's Discussions on Twitter

Confronta FGEN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
FGEN	0.378	35.27M	147.75M	-284.23M	-317.54M	-3.39
VRTX	449.87	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	745.58	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	595.99	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	246.18	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	108.15	24.89B	3.30B	-501.07M	1.03B	11.54

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-08-08	Downgrade	BofA Securities	Neutral → Underperform
2023-06-26	Downgrade	BofA Securities	Buy → Neutral
2023-06-26	Downgrade	Raymond James	Outperform → Mkt Perform
2023-06-26	Downgrade	Stifel	Buy → Hold
2023-06-26	Downgrade	William Blair	Outperform → Mkt Perform
2023-06-02	Aggiornamento	Stifel	Hold → Buy
2023-01-31	Aggiornamento	William Blair	Mkt Perform → Outperform
2023-01-26	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-01-05	Aggiornamento	BofA Securities	Neutral → Buy
2021-09-22	Downgrade	Goldman	Neutral → Sell
2021-08-20	Aggiornamento	Raymond James	Underperform → Mkt Perform
2021-07-16	Downgrade	BofA Securities	Buy → Neutral
2021-07-16	Downgrade	Stifel	Buy → Hold
2021-04-07	Downgrade	H.C. Wainwright	Buy → Neutral
2021-04-07	Downgrade	Mizuho	Buy → Neutral
2021-03-31	Aggiornamento	BofA Securities	Neutral → Buy
2021-03-02	Downgrade	Jefferies	Buy → Hold
2021-02-01	Iniziato	H.C. Wainwright	Buy
2020-10-26	Iniziato	Raymond James	Underperform
2020-07-10	Ripresa	Stifel	Buy
2020-05-01	Iniziato	Cowen	Market Perform
2020-04-27	Iniziato	BofA/Merrill	Neutral
2019-05-29	Ripresa	Goldman	Neutral
2019-05-10	Downgrade	William Blair	Outperform → Mkt Perform
2019-04-12	Iniziato	Piper Jaffray	Neutral
2019-02-11	Ripresa	Stifel	Buy
2018-12-19	Aggiornamento	Citigroup	Neutral → Buy
2017-08-08	Reiterato	Leerink Partners	Outperform
2017-08-08	Reiterato	Stifel	Buy
2017-07-21	Downgrade	Goldman	Buy → Neutral
2017-07-11	Iniziato	Jefferies	Buy
2016-02-11	Aggiornamento	Credit Suisse	Neutral → Outperform
2016-01-21	Iniziato	Credit Suisse	Neutral
2015-12-04	Iniziato	Citigroup	Buy
2015-09-23	Iniziato	Lake Street	Hold
2015-07-29	Iniziato	Citigroup	Buy
2015-07-20	Aggiornamento	Goldman	Neutral → Buy
2014-12-09	Iniziato	Stifel	Buy

Mostra tutto

Fibrogen Inc Borsa (FGEN) Ultime notizie

Nov 16, 2024

FGEN stock touches 52-week low at $0.19 amid market challenges - Investing.com India

Nov 13, 2024

FibroGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

FibroGen, Inc. (NASDAQ:FGEN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Earnings call: FibroGen reports strong Q3 sales, advances in oncology pipeline - Investing.com UK

Nov 13, 2024

FibroGen: Q3 Earnings Snapshot - mySA

Nov 13, 2024